OBJECTIVE: Bax-interacting factor 1 (Bif-1) protein plays a critical role in apoptosis, mitochondrial morphogenesis, and autophagy, and its loss promotes tumorigenesis. The role of Bif-1 in pancreatic cancer has not been studied. METHODS: We determined Bif-1 expression in 82 human pancreatic ductal adenocarcinomas (PDCs) and in 82 nonmalignant pancreatic specimens (NMPs), using immunohistochemistry and tissue microarray. Bif-1 immunostain was semiquantitatively scored on a scale of 0 to 9. RESULTS: Bif-1 scores in NMP were either 6 or 9, with lower scores in only 19 (23.2%) of 82 NMPs. Low Bif-1 expression (score <6) was found in 37 (45.1%) of 82 PDCs, a proportion significantly greater than that found in NMP (P = 0.005). The expression of Bif-1 was twice as likely to be low in PDC as in NMP (relative risk = 1.95, 95% confidence interval, 1.23-3.09). Kaplan-Meier survival estimates showed no difference in survival between patients with low and high Bif-1 expression (P = 0.21, log-rank test). CONCLUSIONS: The expression of Bif-1 is downregulated in a subset of PDC. This novel finding is in agreement with the tumor suppressor function of Bif-1. The lack of association between Bif-1 expression and patient survival may be best explained by the complexity of carcinogenesis.
OBJECTIVE:Bax-interacting factor 1 (Bif-1) protein plays a critical role in apoptosis, mitochondrial morphogenesis, and autophagy, and its loss promotes tumorigenesis. The role of Bif-1 in pancreatic cancer has not been studied. METHODS: We determined Bif-1 expression in 82 humanpancreatic ductal adenocarcinomas (PDCs) and in 82 nonmalignant pancreatic specimens (NMPs), using immunohistochemistry and tissue microarray. Bif-1 immunostain was semiquantitatively scored on a scale of 0 to 9. RESULTS:Bif-1 scores in NMP were either 6 or 9, with lower scores in only 19 (23.2%) of 82 NMPs. Low Bif-1 expression (score <6) was found in 37 (45.1%) of 82 PDCs, a proportion significantly greater than that found in NMP (P = 0.005). The expression of Bif-1 was twice as likely to be low in PDC as in NMP (relative risk = 1.95, 95% confidence interval, 1.23-3.09). Kaplan-Meier survival estimates showed no difference in survival between patients with low and high Bif-1 expression (P = 0.21, log-rank test). CONCLUSIONS: The expression of Bif-1 is downregulated in a subset of PDC. This novel finding is in agreement with the tumor suppressor function of Bif-1. The lack of association between Bif-1 expression and patient survival may be best explained by the complexity of carcinogenesis.
Authors: E M Castellà; A Ariza; I Ojanguren; J L Mate; X Roca; A Fernández-Vasalo; J J Navas-Palacios Journal: Virchows Arch Date: 1996-11 Impact factor: 4.064
Authors: Domenico Coppola; Cecilia Oliveri; Zena Sayegh; David Boulware; Yoshinori Takahashi; Julio Pow-Sang; Julie Y Djeu; Hong-Gang Wang Journal: Clin Genitourin Cancer Date: 2008-09 Impact factor: 2.872
Authors: Jun Wan; Anthony Y Cheung; Wing-Yu Fu; Chengbiao Wu; Mingjie Zhang; William C Mobley; Zelda H Cheung; Nancy Y Ip Journal: J Neurosci Date: 2008-09-03 Impact factor: 6.167
Authors: Su Young Kim; Young Lyun Oh; Kyung Mee Kim; Eun Goo Jeong; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee Journal: Pathology Date: 2008-10 Impact factor: 5.306
Authors: D Cantero; H Friess; J Deflorin; A Zimmermann; M A Bründler; E Riesle; M Korc; M W Büchler Journal: Br J Cancer Date: 1997 Impact factor: 7.640
Authors: Kristin B Runkle; Cheryl L Meyerkord; Neelam V Desai; Yoshinori Takahashi; Hong-Gang Wang Journal: Cancer Biol Ther Date: 2012-08-01 Impact factor: 4.742
Authors: Yoon Ho Ko; Young-Seok Cho; Hye Sung Won; Ho Jung An; Der Sheng Sun; Soon Uk Hong; Jin Hee Park; Myung Ah Lee Journal: Biomed Res Int Date: 2013-09-23 Impact factor: 3.411
Authors: Jordan M Winter; Laura H Tang; David S Klimstra; Murray F Brennan; Jonathan R Brody; Flavio G Rocha; Xiaoyu Jia; Li-Xuan Qin; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; William R Jarnagin; Eileen M O'Reilly; Peter J Allen Journal: PLoS One Date: 2012-07-06 Impact factor: 3.240